Pages that link to "Q54546717"
Jump to navigation
Jump to search
The following pages link to High EVI1 levels predict adverse outcome in acute myeloid leukemia: prevalence of EVI1 overexpression and chromosome 3q26 abnormalities underestimated. (Q54546717):
Displaying 50 items.
- Phosphorylation of the leukemic oncoprotein EVI1 on serine 196 modulates DNA binding, transcriptional repression and transforming ability (Q21133010) (← links)
- Pbx1 is a downstream target of Evi-1 in hematopoietic stem/progenitors and leukemic cells (Q24317653) (← links)
- Haploinsufficiency of SAMD9L, an endosome fusion facilitator, causes myeloid malignancies in mice mimicking human diseases with monosomy 7 (Q24328884) (← links)
- Recurring mutations found by sequencing an acute myeloid leukemia genome (Q24634204) (← links)
- Recent progress toward epigenetic therapies: the example of mixed lineage leukemia (Q26863577) (← links)
- Allogeneic stem cell transplantation in first complete remission (Q26996818) (← links)
- Molecular prognostic factors in cytogenetically normal acute myeloid leukemia (Q26998811) (← links)
- The increased expression of integrin α6 (ITGA6) enhances drug resistance in EVI1(high) leukemia (Q28479144) (← links)
- EVI1 activation in blast crisis CML due to juxtaposition to the rare 17q22 partner region as part of a 4-way variant translocation t(9;22). (Q33350395) (← links)
- PR-domain-containing Mds1-Evi1 is critical for long-term hematopoietic stem cell function (Q33395759) (← links)
- Myeloid neoplasm with t(3;8)(q26;q24): report of six cases and review of the literature (Q33412515) (← links)
- The mTOR inhibitor everolimus in combination with azacitidine in patients with relapsed/refractory acute myeloid leukemia: a phase Ib/II study (Q33437313) (← links)
- Identification of two critically deleted regions within chromosome segment 7q35-q36 in EVI1 deregulated myeloid leukemia cell lines (Q33525049) (← links)
- Acetylation of lysine 564 adjacent to the C-terminal binding protein-binding motif in EVI1 is crucial for transcriptional activation of GATA2. (Q33883148) (← links)
- Molecular characterization of the rare translocation t(3;10)(q26;q21) in an acute myeloid leukemia patient (Q33960024) (← links)
- Acetylation of the proto-oncogene EVI1 abrogates Bcl-xL promoter binding and induces apoptosis (Q34043133) (← links)
- Repetitive busulfan administration after hematopoietic stem cell gene therapy associated with a dominant HDAC7 clone in a nonhuman primate (Q34123262) (← links)
- Acute myeloid leukaemia in adults (Q34327218) (← links)
- Maintenance of the hematopoietic stem cell pool in bone marrow niches by EVI1-regulated GPR56. (Q34332196) (← links)
- Assessing karyotype precision by microarray-based comparative genomic hybridization in the myelodysplastic/myeloproliferative syndromes (Q34400180) (← links)
- High DNA methyltransferase DNMT3B levels: a poor prognostic marker in acute myeloid leukemia (Q34516815) (← links)
- Aberrant DNA hypermethylation signature in acute myeloid leukemia directed by EVI1. (Q34568861) (← links)
- EVI1 inhibits apoptosis induced by antileukemic drugs via upregulation of CDKN1A/p21/WAF in human myeloid cells (Q34606698) (← links)
- Genetic pathways leading to therapy-related myeloid neoplasms (Q35039992) (← links)
- Mice carrying a hypomorphic Evi1 allele are embryonic viable but exhibit severe congenital heart defects (Q35107227) (← links)
- Down-regulation of EVI1 is associated with epigenetic alterations and good prognosis in patients with acute myeloid leukemia (Q35265855) (← links)
- Evi1 is essential for hematopoietic stem cell self-renewal, and its expression marks hematopoietic cells with long-term multilineage repopulating activity (Q35669072) (← links)
- Ecotopic viral integration site 1 (EVI1) regulates multiple cellular processes important for cancer and is a synergistic partner for FOS protein in invasive tumors (Q35750824) (← links)
- Targeted next-generation sequencing reveals high frequency of mutations in epigenetic regulators across treatment-naïve patient melanomas (Q35896475) (← links)
- Persistent polyclonal binucleated B-cell lymphocytosis and MECOM gene amplification (Q35943639) (← links)
- Chromosomal aberrations associated with clonal evolution and leukemic transformation in fanconi anemia: clinical and biological implications (Q36004687) (← links)
- EVI1 acts as an inducible negative-feedback regulator of NF-κB by inhibiting p65 acetylation (Q36016473) (← links)
- EVI1 is critical for the pathogenesis of a subset of MLL-AF9-rearranged AMLs. (Q36057626) (← links)
- The PU.1-Modulated MicroRNA-22 Is a Regulator of Monocyte/Macrophage Differentiation and Acute Myeloid Leukemia (Q36129863) (← links)
- Clinical and prognostic significance of 3q26.2 and other chromosome 3 abnormalities in CML in the era of tyrosine kinase inhibitors (Q36219652) (← links)
- RUNX1-Evi-1 fusion gene inhibited differentiation and apoptosis in myelopoiesis: an in vivo study (Q36379789) (← links)
- Cell of origin determines clinically relevant subtypes of MLL-rearranged AML (Q36409664) (← links)
- miR-133 regulates Evi1 expression in AML cells as a potential therapeutic target (Q36453826) (← links)
- A novel PAD4/SOX4/PU.1 signaling pathway is involved in the committed differentiation of acute promyelocytic leukemia cells into granulocytic cells (Q36772066) (← links)
- Prediction of molecular subtypes in acute myeloid leukemia based on gene expression profiling (Q37059396) (← links)
- EVI1 oncoprotein interacts with a large and complex network of proteins and integrates signals through protein phosphorylation (Q37068625) (← links)
- High EVI1 expression is associated with MLL rearrangements and predicts decreased survival in paediatric acute myeloid leukaemia: a report from the children's oncology group (Q37125803) (← links)
- Induction of Chromosomal Instability via Telomere Dysfunction and Epigenetic Alterations in Myeloid Neoplasia (Q37226494) (← links)
- Clinical implications of molecular genetic aberrations in acute myeloid leukemia (Q37363129) (← links)
- Interactive diagnostics in the indication to allogeneic SCT in AML. (Q37442649) (← links)
- How and why minimal residual disease studies are necessary in leukemia: a review from WP10 and WP12 of the European LeukaemiaNet (Q37545067) (← links)
- EVI1 expression in childhood acute lymphoblastic leukaemia is not restricted to MLL and BCR/ABL rearrangements and is influenced by age. (Q37555328) (← links)
- Potential role of micro-RNAs in head and neck tumorigenesis. (Q37705222) (← links)
- Evi-1 as a critical regulator of leukemic cells (Q37763616) (← links)
- Molecular diagnosis of acute myeloid leukemia (Q37809866) (← links)